Synopsis
0
USDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
EU-WC
NDC
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Enoxolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Enoxolone manufacturer or Enoxolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Enoxolone manufacturer or Enoxolone supplier.
PharmaCompass also assists you with knowing the Enoxolone API Price utilized in the formulation of products. Enoxolone API Price is not always fixed or binding as the Enoxolone Price is obtained through a variety of data sources. The Enoxolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 18alpha-Glycyrrhetinic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 18alpha-Glycyrrhetinic acid, including repackagers and relabelers. The FDA regulates 18alpha-Glycyrrhetinic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 18alpha-Glycyrrhetinic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 18alpha-Glycyrrhetinic acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 18alpha-Glycyrrhetinic acid supplier is an individual or a company that provides 18alpha-Glycyrrhetinic acid active pharmaceutical ingredient (API) or 18alpha-Glycyrrhetinic acid finished formulations upon request. The 18alpha-Glycyrrhetinic acid suppliers may include 18alpha-Glycyrrhetinic acid API manufacturers, exporters, distributors and traders.
click here to find a list of 18alpha-Glycyrrhetinic acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 18alpha-Glycyrrhetinic acid Drug Master File in Japan (18alpha-Glycyrrhetinic acid JDMF) empowers 18alpha-Glycyrrhetinic acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 18alpha-Glycyrrhetinic acid JDMF during the approval evaluation for pharmaceutical products. At the time of 18alpha-Glycyrrhetinic acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 18alpha-Glycyrrhetinic acid suppliers with JDMF on PharmaCompass.
A 18alpha-Glycyrrhetinic acid CEP of the European Pharmacopoeia monograph is often referred to as a 18alpha-Glycyrrhetinic acid Certificate of Suitability (COS). The purpose of a 18alpha-Glycyrrhetinic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 18alpha-Glycyrrhetinic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 18alpha-Glycyrrhetinic acid to their clients by showing that a 18alpha-Glycyrrhetinic acid CEP has been issued for it. The manufacturer submits a 18alpha-Glycyrrhetinic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a 18alpha-Glycyrrhetinic acid CEP holder for the record. Additionally, the data presented in the 18alpha-Glycyrrhetinic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 18alpha-Glycyrrhetinic acid DMF.
A 18alpha-Glycyrrhetinic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 18alpha-Glycyrrhetinic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 18alpha-Glycyrrhetinic acid suppliers with CEP (COS) on PharmaCompass.
A 18alpha-Glycyrrhetinic acid written confirmation (18alpha-Glycyrrhetinic acid WC) is an official document issued by a regulatory agency to a 18alpha-Glycyrrhetinic acid manufacturer, verifying that the manufacturing facility of a 18alpha-Glycyrrhetinic acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 18alpha-Glycyrrhetinic acid APIs or 18alpha-Glycyrrhetinic acid finished pharmaceutical products to another nation, regulatory agencies frequently require a 18alpha-Glycyrrhetinic acid WC (written confirmation) as part of the regulatory process.
click here to find a list of 18alpha-Glycyrrhetinic acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 18alpha-Glycyrrhetinic acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 18alpha-Glycyrrhetinic acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 18alpha-Glycyrrhetinic acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 18alpha-Glycyrrhetinic acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 18alpha-Glycyrrhetinic acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 18alpha-Glycyrrhetinic acid suppliers with NDC on PharmaCompass.
18alpha-Glycyrrhetinic acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 18alpha-Glycyrrhetinic acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 18alpha-Glycyrrhetinic acid GMP manufacturer or 18alpha-Glycyrrhetinic acid GMP API supplier for your needs.
A 18alpha-Glycyrrhetinic acid CoA (Certificate of Analysis) is a formal document that attests to 18alpha-Glycyrrhetinic acid's compliance with 18alpha-Glycyrrhetinic acid specifications and serves as a tool for batch-level quality control.
18alpha-Glycyrrhetinic acid CoA mostly includes findings from lab analyses of a specific batch. For each 18alpha-Glycyrrhetinic acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
18alpha-Glycyrrhetinic acid may be tested according to a variety of international standards, such as European Pharmacopoeia (18alpha-Glycyrrhetinic acid EP), 18alpha-Glycyrrhetinic acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (18alpha-Glycyrrhetinic acid USP).
